Mather Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
10,914
+7,035
| +181% | +$194K | ﹤0.01% | 494 |
|
|
2025
Q1 | $110K | Buy |
3,879
+3,201
| +472% | +$90.8K | ﹤0.01% | 723 |
|
|
2024
Q4 | $28.2K | Sell |
678
-603
| -47% | -$25.1K | ﹤0.01% | 992 |
|
|
2024
Q3 | $85.6K | Buy |
1,281
+262
| +26% | +$17.5K | ﹤0.01% | 770 |
|
|
2024
Q2 | $109K | Buy |
1,019
+443
| +77% | +$47.2K | ﹤0.01% | 786 |
|
|
2024
Q1 | $57.3K | Buy |
+576
| New | +$57.3K | ﹤0.01% | 843 |
|
|
2023
Q1 | – | Sell |
-6,599
| Closed | -$1.19M | – | 516 |
|
|
2022
Q4 | $1.19M | Sell |
6,599
-601
| -8% | -$108K | 0.02% | 186 |
|
|
2022
Q3 | $851K | Sell |
7,200
-531
| -7% | -$62.8K | 0.02% | 217 |
|
|
2022
Q2 | $1.1M | Buy |
7,731
+1,836
| +31% | +$262K | 0.03% | 168 |
|
|
2022
Q1 | $1.02M | Buy |
+5,895
| New | +$1.02M | 0.02% | 169 |
|